Concepedia

John W. Moroney

JW

32

Publications

3.9K

Citations

24

H-Index

1978

Active since

Affiliations

University of Chicago(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

University of Pennsylvania

University of Oklahoma Health Sciences Center

John W. Moroney is an author at University of Chicago specializing in oncology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1978–2025

32

Publications

32

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

Toshihiko Tanno, Natarajan V. Bhanu, Patricia O’Neal et al. · Nature Medicine · 2007 · 830 citations

, , +12

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison et al. · Journal of Clinical Oncology · 2018 · 574 citations

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal et al. · JAMA Oncology · 2019 · 533 citations · Full text

<i>PIK3CA</i> Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors

Filip Jankú, Apostolia M. Tsimberidou, Ignacio Garrido‐Laguna et al. · Molecular Cancer Therapeutics · 2011 · 328 citations · Full text

, , +15

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny et al. · New England Journal of Medicine · 2023 · 316 citations · Full text

Rows per page

1–5 of 32